ClinicalTrials.gg
CompletedNCT03775551BIDCR-RUpdated Apr 23, 2024

Counter-referral System Improvement Collaborative

An interventional study of Improvement cycle in Cardiovascular Diseases and Quality Improvement, sponsored by Institute for Clinical Effectiveness and Health Policy. Completed at 10 sites in Argentina. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-23.

Sponsored by Institute for Clinical Effectiveness and Health Policy · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jun 2018, registered Dec 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
510
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Coordination between different levels of care has been identified as one of the main components of care among people with chronic diseases. In this sense, an adequate referral and counter-reference system facilitates the management of the care process with timely access to the required referral. The objective of this project is to evaluate the effectiveness of a multicomponent strategy that improves the counter- referral process in patients with cardiovascular diseases in the public health system.

Population: The study will be carried out in selected hospitals of the provinces of Mendoza, Tucumán and Salta in Argentina. Patients who have been hospitalized with a diagnosis of heart failure, hypertension (requires hospitalization) and / or coronary disease (unstable angina) will be included.

Design and methods: a Randomized clinical study by clusters. 10 hospital will be included: 5 will be randomly assigned to receive an intervention to increase the improve counter referral rates (improvement cycles) and 5 to the control branch (usual care). 51 participants will be included in each hospital, in total, 510 participants.

Intervention: An innovative vision is proposed, which combines a participatory and dynamic methodology based on improvement cycles. This approach includes the implementation of participatory learning sessions for health providers, involving the effectors of the design of the intervention. In the intervention branch at least 6 workshops (sessions) will be held with the members of the care system, in order to identify opportunities for improvement oriented to the design and application of an innovative intervention based on best practices. Each one of the sessions will constitute an analysis of the improvement cycle, following the following steps: 1) Selection of participants of the initial workshop; 2) Development of work model based on bibliographic review and initial qualitative phase; 3) Initial workshop with effectors for training in continuous improvement, objectives, interventions and data collection; 4) Learning workshops to discuss results, applicability of interventions and modifications to the work plan; 5) Closing session to evaluate preliminary results and discuss continuity of interventions beyond the project.

Outcomes: 1) consultation in the PHC after hospital discharge; 2) readmission's; 3) consultations in the hospital; 4) follow-up in the PHC; 5) patient perspective (satisfaction).

02

Conditions studied

  • Cardiovascular Diseases
  • Quality Improvement

Keywords

  • quality improvement
  • collaborative
  • counter reference
03

In context

Cardiovascular Diseases

5,025 studies on the registry are indexed under Cardiovascular Diseases; 928 are open to participants now.

This study's enrollment of 510 is above the median of 100 across 2,801 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Institute for Clinical Effectiveness and Health Policy is the lead sponsor of 9 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects that only have public health coverage or PAMI
  • Adults over 18 year of age
  • Patients admitted to the hospital with diagnosis of: non valvular heart failure and/or complicated hypertension ( that requires hospitalization) and/or coronary heart disease ( unstable angina)
  • Residence in the area of influence of the hospitals

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • Anticoagulated patients
  • People who are immobilized
  • People who do not give their informed consent
  • People who plan to move in the next 3 months
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
510 participants (actual)

Study arms

  • No intervention
    Control

    The participants belonging to the hospitals assigned to the control group the health providers will give feedback on their health condition and will advise on how to follow up their care after discharge or referral back to PHC following usual practice.

  • Experimental
    Improvement cycle

    In participants belonging to the hospitals assigned to the intervention group,the health providers will give feedback on their health condition and will advise on how to follow up their care after discharge or referral back to PHC using innovative intervention to assure continuity of care and assistant level approach. This innovations will be crafted from the rapid improvement cycles considering the environment and key aspects of the every day care at the participating centers.

    Behavioral: Improvement cycle

Interventions

  • BehavioralImprovement cycle

    at least 6 workshops (sessions) will be held with the members of the care system, in order to identify opportunities for improvement oriented to the design and application of an innovative intervention based on best practices.

    Also known as: quality improvement cycle

06

What researchers measure

Primary outcomes

  1. Patients visits in a primary health center (PHC) after hospital discharge

    proportion of visits made in a primary care center (PHC) after hospital discharge

    Time frame: 3 months after enrollment and/or end of study

Secondary outcomes

  1. Effective counter reference performed by physicians

    proportion of documented ( written) counter references by hospital physicians to a PHC

    Time frame: 3 months after enrollment and/or end of study

  2. Time to the first consultation in a PHC after the hospital discharge

    mean number of days upon patient hospital discharged to the first visit in a primary care center

    Time frame: 3 months after enrollment and/or .end of study

  3. Cardiovascular hospital readmission's

    proportion of re-admissions for the same primary admission condition for which the patient was discharged within the first 90 days

    Time frame: 3 months after enrollment and/or end of study

  4. Cardiovascular re consultations at the second level of care

    proportions of cardiovascular consultations at the secondary level of care after hospital discharge that should have been performed at the first level of care related to the condition for which the patient was included and admitted to the hospital

    Time frame: 3 months after enrollment and/or end of study

  5. Patients satisfaction with the primary health level measured by adapted PCAT questions

    patients satisfaction with the health care provided at the PHC measured by adapted PTCA questions. The Primary Care Assessment Tool was design to evaluate attainment of features in primary care settings. Attributes identified by the tool are first contact accessibility and use, continuity, and coordination in the primary level. The tool has been adapted and validated in several countries and settings. The global index for evaluation will be composed as the sum of 10 items, ranging from 10 to 40. To facilitate interpretation the score will be transformed to a scale of 0 -100 points ( score =100 x (sum -10)/40-10), with higher score indicating more favorable satisfaction.

    Time frame: 4 months

07

Study locations

10 sites
  • Hospital A Italo Perrupato
    San Martin, Mendoza Province, Argentina
  • Hospital Teodoro J. Schestakow
    San Rafael, Mendoza Province, Argentina
  • Hospital Antonio J. Scaravelli
    Tunuyan, Mendoza Province, Argentina
  • Hospital N. Joaquín Castellano
    General Guemes, Salta Province, Argentina
  • Hospital Centro de Salud Zenón J. Santillán
    San Miguel de Tucumán, Tucumán Province, Argentina
  • Hospital Ángel C. Padilla
    San Miguel de Tucumán, Tucumán Province, Argentina
  • Hospital Central
    Mendoza, Argentina
  • Hospital Luis Lagomaggiore
    Mendoza, Argentina
  • Hospital Papa Francisco
    Salta, Argentina
  • Hospital San Bernardo
    Salta, Argentina
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03775551
Lead sponsor
Institute for Clinical Effectiveness and Health Policy
Collaborators
Ministry of Public Health, Argentina
Responsible party
Sponsor
First posted
Dec 14, 2018
Start date
Jun 8, 2018
Primary completion
Dec 1, 2019
Completion
Dec 1, 2019
Last update
Apr 23, 2024

Study contacts

Vilma Irazola, MD
principal investigator · Institute for Clinical Effectiveness and Health Policy
Ezequiel García Elorrio, PhD
principal investigator · Institute for Clinical Effectiveness and Health Policy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion